Pfizer Australia’s Breakthrough Nation report calls on the Australian Government to establish a Life Sciences Vision for the country.

We firmly believe the life sciences sector should be central to our national economic growth as we diversify beyond reliance on primary industries. 

Australia’s high quality research institutions and strong public hospital system make it a prime candidate for further investment. But in the absence of clear vision from government outlining priorities, Australia has not been a focus for life sciences investment. 

As a precursor to any government statement on the role of the life sciences sector in Australia, Pfizer has identified five key themes and corresponding recommendations that it sees as central to addressing the challenges faced across the life sciences industry and our health system:

1. Deliver a prevention revolution to prepare for future threats.

2. Ensure no patient is left behind.

3. Accelerate equitable access to new medicines and vaccines.

4. Make Australia an attractive destination for international investments in life sciences.

5. Unite across the life sciences sector to deliver a net zero health system.Pfizer Australia’s Breakthrough Nation report calls on the Australian Government to establish a Life Sciences Vision for the country.

Breakthrough Nation establishes priorities for the sector to attract investment into research and development, clinical trials and manufacturing in Australia. 

Pfizer’s manufacturing site in Melbourne is an important part of our global supply model. The facility employs around 500 people and manufactures oncology medicines and antimicrobials that are exported to over 60 countries.

Pfizer recently reached an important construction milestone in our AU$150M upgrade of our Melbourne manufacturing site, making it one of the most advanced pharmaceutical production facilities in Australia. The investment enabled the construction of a new fully segregated building on the site, and a new manufacturing line. The upgrade also includes productivity enhancements through robotics and AI technology and will help ensure the site continues to operate at the cutting edge of highly specialised manufacturing.